Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
it's not about the herd misunderstaning the rns... it's about the fact that this shows there's a belief that this isn't a bust and is still the same pharma as it was before the fda knock back... as such, it's about reclaiming the lost sp over and above how it looked last week... that's all... but it's enough to put a boost under the confidence in the roduct and the sp.
Morning, yes agree. Another big vote of confidence for Iclaprim.
The recent presentation, new NED appointment and now an agreement all point to confidence in approval by the FDA.
If this is approved its is massively under valued and mcap will multiply many times.
completely agree
I've no idea what the significance of the agreement will prove to be in the long run but for me its main significance now is that at a time when you would have expected motif to be devoting all its resources and efforts into the FDA meeting and possible subsequent steps it has found time to conclude the agreement.no idea how much effort it has taken but for me its a fairly strong indication of confidence in the overall situation. very good news imo
Another great update.
With the recent NED announcement and now this news plus the fact two experts are going to the FDA meeting on friday suggests MTFB are extremely confident of a positive outcome.
Today's news should give the FDA plenty of food for thought in that Iclaprim is a versatile drug substance for lung related infections giving even more impetus for a favorable decision (and hopefully quick NDA).
Will end flat imo. This isn’t rocketing price news it’s more herd not reading and understanding the rns. Will drift down and end up flat or couple percent up imo at close
Probably won't reach any dizzy heights today as people take profits to quickly but a slow rise is equally as good. It is always funny when the SAR mob come and talk us down and we go quietly up.
Yup after 14:30 today, fireworks time.
Wait for fireworks mid day with Nasdaq
today's arrangement shows that thee's going to be continued life in the pharma, in spite of the fda hiccup (and that's all it's now likely to have been).
will be relieved to see 12p today and squeeze a little more for a good support into the meeting.
oh, and if you're passing SAR, say hello to thoth... his share's languishing, in comparison!
About 10p
Any opinion on closing price today?
Think buys flooding in, keeps goong on auction with bid keep going up.
May go up with pressure building up
Market doesn’t know how to price this what is clearly being taken as good news MMS won’t know where to place it and we know they struggle to hold it when it moves quickly Ante is up
Auction again at 11.00 - 11.02
Here we go
May jump
Another positive for this share, so way under valued now :-)
That we’re not going anywhere because Iclaprim is an important addition in the global requirement for new antibiotics that work in multiple indications
New agreement
If you were really invested , would you deramp your share so much ?? At best your shorting or at worst your paid to cause mischef. Either way go and bother some other bb. Everyone can see through your blaintent bs. Goodbye